Nevertheless, PSA is not a specific marker for prostate cancer, and TRUS-guided prostate biopsy is associated with infection and other adverse effects and can lead to false negative results in up to 25% of cases.2 This evidence concerns the gene KLK3 and Familial prostate cancer.